• Consensus Rating: N/A
  • Consensus Price Target: A$0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
A$0.00
+0 (0.00%)
Get New Cochlear Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for COH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for COH

Analyst Price Target is A$0.00
This price target is based on 0 analysts offering 12 month price targets for Cochlear in the last 3 months. The average price target is A$0.00, with a high forecast of A$0.00 and a low forecast of A$10,000,000.00. The average price target represents a NaN upside from the last price of A$0.00.

This chart shows the closing price for COH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Cochlear. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/5/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/30/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/29/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/20/2018The Goldman Sachs GroupUpgradeBuy
12/20/2018Deutsche Bank AktiengesellschaftUpgradeBuy
12/20/2018Jefferies Financial GroupSet TargetBuy$53.00
(Data available from 1/29/2018 forward)

News Sentiment Rating

0.83 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/3/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/2/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/1/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/1/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/31/2022
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/30/2022
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/30/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/29/2023

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Cochlear logo
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

201,277 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

1.39%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Cochlear?

The following sell-side analysts have issued reports on Cochlear in the last twelve months:
View the latest analyst ratings for COH.

What is the current price target for Cochlear?

0 Wall Street analysts have set twelve-month price targets for Cochlear in the last year. has the lowest price target set, forecasting a price of A$10,000,000.00 for Cochlear in the next year.
View the latest price targets for COH.

What is the current consensus analyst rating for Cochlear?

Cochlear currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for COH.

What other companies compete with Cochlear?

Other companies that are similar to Cochlear include 4DMedical, Adherium, Allegra Orthopaedics, Analytica and AnteoTech. Learn More about companies similar to Cochlear.

How do I contact Cochlear's investor relations team?

Cochlear's physical mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company's listed phone number is +61-2-94286555. The official website for Cochlear is www.cochlear.com. Learn More about contacing Cochlear investor relations.